Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec)

NEXT STORY
Novan to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
PREV STORY
Myriad Genetics Receives First Reimbursement Decision for myChoice® Diagnostic System in Japan, Enabling Women with Ovarian Cancer to Benefit from Treatment with Zejula®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biothera Pharmaceuticals Enters Cancer Immunotherapy Clinical Trial Collaboration Agreement

EAGAN, Minn., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced that ...

author_avatar
NASDAQ Market News

Capital Digestive Care Taps Ramsey Daher, MD for Its Metro Offices

Board-certified gastroenterologist now seeing patients in DC and Chevy Chase, MDSilver Spring, MD, Feb. ...

author_avatar
NASDAQ Market News

Echo Health Ventures Joins Strive Health’s Investor Group to Help Transform Kidney Care for Patients

SEATTLE, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Echo Health Ventures (EHV), a strategic collaboration ...

author_avatar
NASDAQ Market News